Abstract 5388: Targeting, biodistribution, and in vivo effects of MV-muPA, a novel oncolytic measles virus fully retargeted against uPAR in syngeneic, immunocompetent cancer models
This output has contributed to the advancement of the following goals:
Source: InCites
Details
Title
Abstract 5388: Targeting, biodistribution, and in vivo effects of MV-muPA, a novel oncolytic measles virus fully retargeted against uPAR in syngeneic, immunocompetent cancer models
Creators
Yuqi Jing
Julia Zaias
Krisztina Kovacs
Jaime Merchan
Publication Details
Cancer research (Chicago, Ill.), Vol.71(8 Supplement), pp.5388-5388
Academic Unit
Miller School of Medicine; UMMG Dept of Medicine - Hematology/Oncology